Ayorinde Soipe, MD
Nephrology · Lawrenceville, GANPI 1073074167
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,096 of the $4,157 with a category attached, or 74.5%. 12 manufacturers reported payments, led by Eli Lilly at 49.9% of the total.
Across 42 payments — averaging $98.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2K
- Alnylam Pharmaceuticals Inc.$2K
- Mallinckrodt Hospital Products Inc.$90
- Amgen$85
- Novartis$56
- Bayer$50
- plus $151 from 6 others
Across 11 payments — averaging $19,870 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$133K
- Alnylam Pharmaceuticals Inc.$81K
- Eli Lilly$4K
What the payments were for
- Travel & lodging$3,09674%
- Food & beverage$1,06126%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 16 | $2,072 |
| Alnylam Pharmaceuticals Inc. | 6 | $1,652 |
| Mallinckrodt Hospital Products Inc. | 4 | $90 |
| Amgen | 4 | $85 |
| Novartis | 3 | $56 |
| Bayer | 2 | $50 |
| Travere Therapeutics, Inc. | 2 | $42 |
| Calliditas Therapeutics US Inc. | 1 | $27 |
| Aurinia Pharma U.S., Inc. | 1 | $26 |
| AstraZeneca | 1 | $21 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $15 |
How this compares
$4,157 in reported general payments places this provider in the 70th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 12 | $5,814 |
| Gabapentin | 13 | $324 |
| Atorvastatin Calcium | 12 | $40 |
| Lisinopril | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Lawrenceville
- James TumlinLawrenceville$434K
- William PaxtonLawrenceville$73K
- Sharad VirmaniLawrenceville$55K
- Lorin SanchezLawrenceville$23K
- Aakash AminLawrenceville$22K
- Kathryn ElmoreLawrenceville$12K
- Shaun ConlonLawrenceville$11K
- Nnamdi NwaohiriLawrenceville$11K
- Jusong ChoiLawrenceville$8K
- Sagar PanseMacon$542K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.